Literature DB >> 14596935

Rescue of functional DeltaF508-CFTR channels by co-expression with truncated CFTR constructs in COS-1 cells.

Grzegorz Owsianik1, Lishuang Cao, Bernd Nilius.   

Abstract

The most frequent mutant variant of the cystic fibrosis transmembrane conductance regulator (CFTR), DeltaF508-CFTR, is misprocessed and subsequently degraded in the endoplasmic reticulum. Using the patch-clamp technique, we showed that co-expressions of DeltaF508-CFTR with the N-terminal CFTR truncates containing bi-arginine (RXR) retention/retrieval motifs result in a functional rescue of the DeltaF508-CFTR mutant channel in COS-1 cells. This DeltaF508-CFTR rescue process was strongly impaired when truncated CFTR constructs possessed either the DeltaF508 mutation or arginine-to-lysine mutations in RXRs. In conclusions, our data demonstrated that expression of truncated CFTR constructs could be a novel promising approach to improve maturation of DeltaF508-CFTR channels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596935     DOI: 10.1016/s0014-5793(03)01162-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Dominant-negative effect of SCN5A N-terminal mutations through the interaction of Na(v)1.5 α-subunits.

Authors:  Jérôme Clatot; Azza Ziyadeh-Isleem; Svetlana Maugenre; Isabelle Denjoy; Haiyan Liu; Gilles Dilanian; Stéphane N Hatem; Isabelle Deschênes; Alain Coulombe; Pascale Guicheney; Nathalie Neyroud
Journal:  Cardiovasc Res       Date:  2012-06-27       Impact factor: 10.787

2.  Functional rescue of a misfolded eukaryotic ATP-binding cassette transporter by domain replacement.

Authors:  Raymond J Louie; Silvere Pagant; Ji-Young Youn; John J Halliday; Gregory Huyer; Susan Michaelis; Elizabeth A Miller
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

3.  A novel strategy using cardiac sodium channel polymorphic fragments to rescue trafficking-deficient SCN5A mutations.

Authors:  Krekwit Shinlapawittayatorn; Lynn A Dudash; Xi X Du; Lisa Heller; Steven Poelzing; Eckhard Ficker; Isabelle Deschênes
Journal:  Circ Cardiovasc Genet       Date:  2011-08-12

4.  Cooperative assembly and misfolding of CFTR domains in vivo.

Authors:  Kai Du; Gergely L Lukacs
Journal:  Mol Biol Cell       Date:  2009-01-28       Impact factor: 4.138

5.  A truncated CFTR protein rescues endogenous DeltaF508-CFTR and corrects chloride transport in mice.

Authors:  Estelle Cormet-Boyaka; Jeong S Hong; Bakhram K Berdiev; James A Fortenberry; Jessica Rennolds; J P Clancy; Dale J Benos; Prosper N Boyaka; Eric J Sorscher
Journal:  FASEB J       Date:  2009-07-20       Impact factor: 5.191

6.  Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation.

Authors:  Estelle Cormet-Boyaka; Michael Jablonsky; Anjaparavanda P Naren; Patricia L Jackson; Donald D Muccio; Kevin L Kirk
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-12       Impact factor: 11.205

Review 7.  The puzzle of TRPV4 channelopathies.

Authors:  Bernd Nilius; Thomas Voets
Journal:  EMBO Rep       Date:  2013-01-11       Impact factor: 8.807

8.  Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia.

Authors:  Fei Sun; Zhibao Mi; Steven B Condliffe; Carol A Bertrand; Xiaoyan Gong; Xiaoli Lu; Ruilin Zhang; Joseph D Latoche; Joseph M Pilewski; Paul D Robbins; Raymond A Frizzell
Journal:  FASEB J       Date:  2008-06-12       Impact factor: 5.191

9.  Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis.

Authors:  Rebecca A Chanoux; Ronald C Rubenstein
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

10.  Rescue of murine F508del CFTR activity in native intestine by low temperature and proteasome inhibitors.

Authors:  Martina Wilke; Alice Bot; Huub Jorna; Bob J Scholte; Hugo R de Jonge
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.